LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.

    Grissenberger, Sarah / Riedl, Sabrina / Rinner, Beate / Leber, Regina / Zweytick, Dagmar

    Biochimica et biophysica acta. Biomembranes

    2020  Volume 1862, Issue 8, Page(s) 183264

    Abstract: The aim of this study was to develop effective and specific anti-cancer drugs based on membrane active peptides. In previous studies we showed that human lactoferricin (hLFcin) derived peptides facilitate specific killing of cancer cells. These antitumor ...

    Abstract The aim of this study was to develop effective and specific anti-cancer drugs based on membrane active peptides. In previous studies we showed that human lactoferricin (hLFcin) derived peptides facilitate specific killing of cancer cells. These antitumor peptides were found by conventional melanoma two-dimensional (2D) cell cultures to induce apoptosis of cancer cells and to specifically target lipid phosphatidylserine located on the outside of cancer cell membranes. In order to have a more relevant in vitro model able to mimic the natural microenvironments of tumor tissues we established three-dimensional (3D) multicellular tumor spheroids (MCTS). We used a set of (retro) di-peptides derived from LF11, an 11 amino acid long fragment of hLFcin, which differed in peptide length, positive net charge and hydrophobicity and determined antitumor activity and non-specific toxicity on non-neoplastic cells using 2D and 3D model systems. 2D studies unveiled a correlation between length, positive net charge and hydrophobicity of peptides and their specific antitumor activity. (Retro) di-peptides as R-DIM-P-LF11-215 and DIM-LF11-322 with a net charge of +9 and moderate hydrophobicity exhibited the highest specific antitumor activity. Further evaluation of the peptides anticancer activity by 3D in vitro studies confirmed their higher activity and cancer specificity compared to their parent R-DIM-P-LF11, with the exception of DIM-LF11-339. This highly hydrophobic peptide caused cell death mainly at the border of tumor spheroids indicating that too high hydrophobicity may prevent peptides from reaching the center of the spheroids.
    MeSH term(s) Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Cell Line, Tumor ; Humans ; Lactoferrin/chemistry ; Lactoferrin/genetics ; Melanoma/drug therapy ; Melanoma/pathology ; Peptides/chemistry ; Peptides/pharmacology ; Spheroids, Cellular/drug effects ; Tumor Microenvironment/drug effects
    Chemical Substances Antineoplastic Agents ; Peptides ; lactoferricin B (146897-68-9) ; Lactoferrin (EC 3.4.21.-)
    Language English
    Publishing date 2020-03-07
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 60-7
    ISSN 1879-2642 ; 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2618 ; 1879-2650 ; 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    ISSN (online) 1879-2642 ; 1879-2596 ; 1879-260X ; 1872-8006 ; 1879-2618 ; 1879-2650
    ISSN 0006-3002 ; 0005-2728 ; 0005-2736 ; 0304-4165 ; 0167-4838 ; 1388-1981 ; 0167-4889 ; 0167-4781 ; 0304-419X ; 1570-9639 ; 0925-4439 ; 1874-9399
    DOI 10.1016/j.bbamem.2020.183264
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Preclinical testing of CAR T cells in zebrafish xenografts.

    Grissenberger, Sarah / Salzer, Benjamin / Pascoal, Susana / Wenninger-Weinzierl, Andrea / Lehner, Manfred / Distel, Martin

    Methods in cell biology

    2021  Volume 167, Page(s) 133–147

    Abstract: Engineered chimeric antigen receptor T cells (CAR T cells) have emerged as a promising immunotherapy for cancer and have proven to be effective for B cell malignancies. Currently, great efforts are undertaken to expand the application of CAR T cells to ... ...

    Abstract Engineered chimeric antigen receptor T cells (CAR T cells) have emerged as a promising immunotherapy for cancer and have proven to be effective for B cell malignancies. Currently, great efforts are undertaken to expand the application of CAR T cells to other cancer entities, to increase the efficacy of CAR T cell-mediated killing of cancer cells and to reduce possible side effects of CAR T cell therapy. This creates a need for preclinical models to test the many emerging novel CAR designs. Traditionally, mouse xenograft models are applied to investigate the efficacy of CAR T cells in vivo. Here, we describe a complementing xenograft protocol for testing CAR T cells against human leukemia cells in zebrafish embryos. The embryonic zebrafish xenograft promises to be a fast and cost-efficient model and particularly offers live imaging opportunities of CAR T cell distribution and killing of cancer cells in vivo.
    MeSH term(s) Animals ; Cell Line, Tumor ; Heterografts ; Humans ; Immunotherapy, Adoptive/methods ; Mice ; Receptors, Antigen, T-Cell/genetics ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/therapeutic use ; T-Lymphocytes ; Zebrafish
    Chemical Substances Receptors, Antigen, T-Cell ; Receptors, Chimeric Antigen
    Language English
    Publishing date 2021-08-20
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 0091-679X
    ISSN 0091-679X
    DOI 10.1016/bs.mcb.2021.07.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts.

    Sturtzel, C / Grissenberger, S / Bozatzi, P / Scheuringer, E / Wenninger-Weinzierl, A / Zajec, Z / Dernovšek, J / Pascoal, S / Gehl, V / Kutsch, A / Granig, A / Rifatbegovic, F / Carre, M / Lang, A / Valtingojer, I / Moll, J / Lötsch, D / Erhart, F / Widhalm, G /
    Surdez, D / Delattre, O / André, N / Stampfl, J / Tomašič, T / Taschner-Mandl, S / Distel, M

    NPJ precision oncology

    2023  Volume 7, Issue 1, Page(s) 44

    Abstract: Zebrafish xenotransplantation models are increasingly applied for phenotypic drug screening to identify small compounds for precision oncology. Larval zebrafish xenografts offer the opportunity to perform drug screens at high-throughput in a complex in ... ...

    Abstract Zebrafish xenotransplantation models are increasingly applied for phenotypic drug screening to identify small compounds for precision oncology. Larval zebrafish xenografts offer the opportunity to perform drug screens at high-throughput in a complex in vivo environment. However, the full potential of the larval zebrafish xenograft model has not yet been realized and several steps of the drug screening workflow still await automation to increase throughput. Here, we present a robust workflow for drug screening in zebrafish xenografts using high-content imaging. We established embedding methods for high-content imaging of xenografts in 96-well format over consecutive days. In addition, we provide strategies for automated imaging and analysis of zebrafish xenografts including automated tumor cell detection and tumor size analysis over time. We also compared commonly used injection sites and cell labeling dyes and show specific site requirements for tumor cells from different entities. We demonstrate that our setup allows us to investigate proliferation and response to small compounds in several zebrafish xenografts ranging from pediatric sarcomas and neuroblastoma to glioblastoma and leukemia. This fast and cost-efficient assay enables the quantification of anti-tumor efficacy of small compounds in large cohorts of a vertebrate model system in vivo. Our assay may aid in prioritizing compounds or compound combinations for further preclinical and clinical investigations.
    Language English
    Publishing date 2023-05-18
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2397-768X
    ISSN 2397-768X
    DOI 10.1038/s41698-023-00386-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Using Zebrafish Larvae as a Xenotransplantation Model to Study Ewing Sarcoma.

    Pascoal, Susana / Grissenberger, Sarah / Scheuringer, Eva / Fior, Rita / Ferreira, Miguel Godinho / Distel, Martin

    Methods in molecular biology (Clifton, N.J.)

    2020  Volume 2226, Page(s) 243–255

    Abstract: Tumor models allowing for the in vivo investigation of molecular mechanisms driving tumor progression and metastasis are important to develop novel strategies for cancer treatment. Unfortunately, for Ewing sarcoma no adequate genetic animal models are ... ...

    Abstract Tumor models allowing for the in vivo investigation of molecular mechanisms driving tumor progression and metastasis are important to develop novel strategies for cancer treatment. Unfortunately, for Ewing sarcoma no adequate genetic animal models are currently available. Mouse xenograft models are the state of the art to model Ewing sarcoma in vivo. Here, we describe an alternative Ewing sarcoma xenograft model in embryonic and larval zebrafish. This xenograft model offers live imaging and easy compound testing opportunities hereby complementing mouse xenograft models. In this chapter, we provide a detailed protocol how to xenograft Ewing sarcoma cells (shSK-E17T) into 2-day-old zebrafish and how xenografted zebrafish can be imaged and analyzed over consecutive days to study tumor proliferation.
    MeSH term(s) Animals ; Biomarkers ; Bone Neoplasms/pathology ; Cell Line, Tumor ; Disease Models, Animal ; Immunohistochemistry ; Larva ; Sarcoma, Ewing/pathology ; Transplantation, Heterologous ; Zebrafish
    Chemical Substances Biomarkers
    Language English
    Publishing date 2020-12-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-1020-6_19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Fast Dynamic

    Mayr, Vanessa / Sturtzel, Caterina / Stadler, Manuela / Grissenberger, Sarah / Distel, Martin

    Frontiers in cell and developmental biology

    2018  Volume 6, Page(s) 111

    Abstract: Precise regulation of signaling pathways in single cells underlies tissue development, maintenance and repair in multicellular organisms, but our ability to monitor signaling dynamics in living vertebrates is currently limited. We implemented kinase ... ...

    Abstract Precise regulation of signaling pathways in single cells underlies tissue development, maintenance and repair in multicellular organisms, but our ability to monitor signaling dynamics in living vertebrates is currently limited. We implemented kinase translocation reporter (KTR) technology to create DREKA ("
    Language English
    Publishing date 2018-09-25
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2737824-X
    ISSN 2296-634X
    ISSN 2296-634X
    DOI 10.3389/fcell.2018.00111
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-X

    Grissenberger, Sarah / Sturtzel, Caterina / Wenninger-Weinzierl, Andrea / Radic-Sarikas, Branka / Scheuringer, Eva / Bierbaumer, Lisa / Etienne, Vesnie / Némati, Fariba / Pascoal, Susana / Tötzl, Marcus / Tomazou, Eleni M / Metzelder, Martin / Putz, Eva M / Decaudin, Didier / Delattre, Olivier / Surdez, Didier / Kovar, Heinrich / Halbritter, Florian / Distel, Martin

    Cancer letters

    2022  Volume 554, Page(s) 216028

    Abstract: Ewing sarcoma is a pediatric bone and soft tissue cancer with an urgent need for new therapies to improve disease outcome. To identify effective drugs, phenotypic drug screening has proven to be a powerful method, but achievable throughput in mouse ... ...

    Abstract Ewing sarcoma is a pediatric bone and soft tissue cancer with an urgent need for new therapies to improve disease outcome. To identify effective drugs, phenotypic drug screening has proven to be a powerful method, but achievable throughput in mouse xenografts, the preclinical Ewing sarcoma standard model, is limited. Here, we explored the use of xenografts in zebrafish for high-throughput drug screening to discover new combination therapies for Ewing sarcoma. We subjected xenografts in zebrafish larvae to high-content imaging and subsequent automated tumor size analysis to screen single agents and compound combinations. We identified three drug combinations effective against Ewing sarcoma cells: Irinotecan combined with either an MCL-1 or an BCL-X
    MeSH term(s) Humans ; Animals ; Mice ; Sarcoma, Ewing/drug therapy ; Sarcoma, Ewing/genetics ; Sarcoma, Ewing/metabolism ; Zebrafish/metabolism ; Myeloid Cell Leukemia Sequence 1 Protein/genetics ; Myeloid Cell Leukemia Sequence 1 Protein/metabolism ; Drug Evaluation, Preclinical ; Heterografts ; Apoptosis ; bcl-X Protein/genetics ; bcl-X Protein/metabolism ; Cell Line, Tumor
    Chemical Substances Myeloid Cell Leukemia Sequence 1 Protein ; bcl-X Protein
    Language English
    Publishing date 2022-12-01
    Publishing country Ireland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 195674-7
    ISSN 1872-7980 ; 0304-3835
    ISSN (online) 1872-7980
    ISSN 0304-3835
    DOI 10.1016/j.canlet.2022.216028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: In vitro

    Riedl, Sabrina / Rinner, Beate / Schaider, Helmut / Liegl-Atzwanger, Bernadette / Meditz, Katharina / Preishuber-Pflügl, Julia / Grissenberger, Sarah / Lohner, Karl / Zweytick, Dagmar

    Oncotarget

    2017  Volume 8, Issue 42, Page(s) 71817–71832

    Abstract: Di-peptides derived from the human host defense peptide lactoferricin were previously described to specifically interact with the negatively charged lipid phosphatidylserine exposed by cancer cells. In this study one further derivative, namely R-DIM-P- ... ...

    Abstract Di-peptides derived from the human host defense peptide lactoferricin were previously described to specifically interact with the negatively charged lipid phosphatidylserine exposed by cancer cells. In this study one further derivative, namely R-DIM-P-LF11-334 is shown to exhibit even increased cancer toxicity
    Language English
    Publishing date 2017-09-22
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2560162-3
    ISSN 1949-2553 ; 1949-2553
    ISSN (online) 1949-2553
    ISSN 1949-2553
    DOI 10.18632/oncotarget.17823
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness.

    Gabler, Lisa / Jaunecker, Carola Nadine / Katz, Sonja / van Schoonhoven, Sushilla / Englinger, Bernhard / Pirker, Christine / Mohr, Thomas / Vician, Petra / Stojanovic, Mirjana / Woitzuck, Valentin / Laemmerer, Anna / Kirchhofer, Dominik / Mayr, Lisa / LaFranca, Mery / Erhart, Friedrich / Grissenberger, Sarah / Wenninger-Weinzierl, Andrea / Sturtzel, Caterina / Kiesel, Barbara /
    Lang, Alexandra / Marian, Brigitte / Grasl-Kraupp, Bettina / Distel, Martin / Schüler, Julia / Gojo, Johannes / Grusch, Michael / Spiegl-Kreinecker, Sabine / Donoghue, Daniel J / Lötsch, Daniela / Berger, Walter

    Acta neuropathologica communications

    2022  Volume 10, Issue 1, Page(s) 65

    Abstract: Glioblastoma (GBM) is characterized by a particularly invasive phenotype, supported by oncogenic signals from the fibroblast growth factor (FGF)/ FGF receptor (FGFR) network. However, a possible role of FGFR4 remained elusive so far. Several ... ...

    Abstract Glioblastoma (GBM) is characterized by a particularly invasive phenotype, supported by oncogenic signals from the fibroblast growth factor (FGF)/ FGF receptor (FGFR) network. However, a possible role of FGFR4 remained elusive so far. Several transcriptomic glioma datasets were analyzed. An extended panel of primary surgical specimen-derived and immortalized GBM (stem)cell models and original tumor tissues were screened for FGFR4 expression. GBM models engineered for wild-type and dominant-negative FGFR4 overexpression were investigated regarding aggressiveness and xenograft formation. Gene set enrichment analyses of FGFR4-modulated GBM models were compared to patient-derived datasets. Despite widely absent in adult brain, FGFR4 mRNA was distinctly expressed in embryonic neural stem cells and significantly upregulated in glioblastoma. Pronounced FGFR4 overexpression defined a distinct GBM patient subgroup with dismal prognosis. Expression levels of FGFR4 and its specific ligands FGF19/FGF23 correlated both in vitro and in vivo and were progressively upregulated in the vast majority of recurrent tumors. Based on overexpression/blockade experiments in respective GBM models, a central pro-oncogenic function of FGFR4 concerning viability, adhesion, migration, and clonogenicity was identified. Expression of dominant-negative FGFR4 resulted in diminished (subcutaneous) or blocked (orthotopic) GBM xenograft formation in the mouse and reduced invasiveness in zebrafish xenotransplantation models. In vitro and in vivo data consistently revealed distinct FGFR4 and integrin/extracellular matrix interactions. Accordingly, FGFR4 blockade profoundly sensitized FGFR4-overexpressing GBM models towards integrin/focal adhesion kinase inhibitors. Collectively, FGFR4 overexpression contributes to the malignant phenotype of a highly aggressive GBM subgroup and is associated with integrin-related therapeutic vulnerabilities.
    MeSH term(s) Animals ; Carcinogenesis ; Glioblastoma/genetics ; Glioblastoma/pathology ; Humans ; Integrins ; Mice ; Neoplasm Recurrence, Local ; Receptor, Fibroblast Growth Factor, Type 4/genetics ; Receptor, Fibroblast Growth Factor, Type 4/metabolism ; Zebrafish/metabolism ; Zebrafish Proteins
    Chemical Substances Integrins ; Zebrafish Proteins ; Receptor, Fibroblast Growth Factor, Type 4 (EC 2.7.10.1) ; fgfr4 protein, zebrafish (EC 2.7.10.1)
    Language English
    Publishing date 2022-04-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2715589-4
    ISSN 2051-5960 ; 2051-5960
    ISSN (online) 2051-5960
    ISSN 2051-5960
    DOI 10.1186/s40478-022-01363-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top